GlassScriptPhysician profile
Kari J Eckhardt
NPI 1548412356
$1,444.45
in general payments reported to CMS, 2019-2025
28 companies · $432 in 2025
The $432 reported for 2025 was more than what 94% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $183 · 2022: $293 · 2023: $218 · 2024: $318 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $968.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $232.15 | 2022-2025 | |
| Biogen, INC. | $207.74 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $130.73 | 2021-2023 | |
| Astellas Pharma US INC | $124.64 | 2024 | Veozah |
| Myovant Sciences INC. | $73.71 | 2021-2022 | |
| Avanos Medical | $65.99 | 2022-2024 | On-Q* Pump and Accessories |
| Smith+Nephew, INC. | $62.55 | 2024-2025 | Pico 7 |
| Daiichi Sankyo INC. | $60.69 | 2021-2023 | Injectafer |
| Shield Therapeutics INC | $43.35 | 2023 | Accrufer |
| Evofem Biosciences, INC. | $42.81 | 2021 | |
| Organon LLC | $36.98 | 2022-2025 | Jada System |
| Exact Sciences Corporation | $35.33 | 2023-2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $33.98 | 2025 | Aptima |
| Avion Pharmaceuticals | $32.33 | 2023 | Balcoltra |
| Merck Sharp & Dohme LLC | $30.39 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25.01 | 2021 | |
| Innovation Technologies INC | $20.60 | 2025 | Irrisept |
| Ethicon US, LLC | $19.45 | 2025 | Dermabond Prineo, Vistaseal, Stratafix |
| Pacira Pharmaceuticals Incorporated | $19.42 | 2021 | |
| Aspira Women'S Health INC | $18.59 | 2024 | Ova1 |
| Abbott Laboratories | $18.17 | 2022 | |
| Agile Therapeutics, INC. | $17.14 | 2021 | |
| Novo Nordisk INC | $16.61 | 2023 | Rybelsus, Ozempic |
| Radius Health, INC. | $16.42 | 2023 | Tymlos |
| Millicent US INC | $16.24 | 2025 | Femlyv |
| Mission Pharmacal Company | $14.98 | 2021 | |
| Exeltis, USA INC. | $14.55 | 2022 | |
| Sumitomo Pharma America, INC. | $13.90 | 2024 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kari Eckhardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.